Eli Lilly slashes costs of weight-loss drug Zepbound for single-use vials
Drugmaker Eli Lilly mentioned Tuesday it’ll promote single-use vials of its weight-loss drug Zepbound at a fragment of the cost of its pens, amid skyrocketing call for amongst American citizens for anti-obesity